Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Palmitoylethanolamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 61Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clearmind Medicine Files US Patent For Metabolic Syndrome Treatment
    Clearmind Medicine Files US Patent For Metabolic Syndrome Treatment

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913567/0/en/Clearmind-Medicine-Announces-Submission-of-US-Patent-Application-for-Treating-Metabolic-Syndrome-and-Weight-loss.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Full Alliance Subsidiary DynaMAXX Launches PRiVIVE™ Topical Serum
    Full Alliance Subsidiary DynaMAXX Launches PRiVIVE™ Topical Serum

    18 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=878852&lang=en

    ACCESSWIRE
    18 Jun 2024
    Share Share
    FDA & Health Canada Clear IND for FSD to Proceed with PII Trial of FSD201
    FDA & Health Canada Clear IND for FSD to Proceed with PII Trial of FSD201

    06 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220906005664/en

    BUSINESSWIRE
    06 Sep 2022
    Share Share
    Lucid Psycheceuticals Files for Patent On Formulations of Palmitoylethanolamide
    Lucid Psycheceuticals Files for Patent On Formulations of Palmitoylethanolamide

    13 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220713005308/en

    BUSINESSWIRE
    13 Jul 2022
    Share Share
    FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial
    FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial

    24 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210824005813/en

    BUSINESSWIRE
    24 Aug 2021
    Share Share
    Advanced Orthomolecular Research Launches P.E.A. Endocannabinoid
    Advanced Orthomolecular Research Launches P.E.A. Endocannabinoid

    22 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/advanced-orthomolecular-research-launches-pea-endocannabinoid-support-to-combat-chronic-inflammation-and-provide-the-benefits-of-cbd-without-the-stigma-300963234.html

    PR NEWSWIRE
    22 Nov 2019
    Share Share